GEMINI LXL CT/PET System. The Philips GEMINI PET/CT Imaging Systems are a family of integrated...

FDA Device Recall #Z-2194-2015 — Class II — July 1, 2015

Recall Summary

Recall Number Z-2194-2015
Classification Class II — Moderate risk
Date Initiated July 1, 2015
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Philips Medical Systems (Cleveland) Inc
Location Cleveland, OH
Product Type Devices
Quantity 2 units

Product Description

GEMINI LXL CT/PET System. The Philips GEMINI PET/CT Imaging Systems are a family of integrated diagnostic X-ray Computed Tomography (CT) and Positron Emission Tomography (PET) systems suitable for a wide range of diagnostic applications.

Reason for Recall

Philips has identified four (4) software defects in the Tumor LOC software application that may potentially result in irradiation of healthy tissue or non-irradiation of diseased tissue.

Distribution Pattern

Worldwide Distribution - US Nationwide, Australia, Belgium, Brazil, Canada, China, Denmark, France, Germany, Israel, Italy, Japan, Lebanon, Netherlands, Portugal, Saudi Arabia, South Africa, Switzerland, Thailand, Venezuela & Vietnam.

Lot / Code Information

Model #882412 GEMINI LXL (459800018631); Serial Number: 14702 & 14707.

Other Recalls from Philips Medical Systems (Cleveland) Inc

Recall # Classification Product Date
Z-2570-2025 Class II Pinnacle Radiation Therapy Planning System: ... Aug 5, 2025
Z-2239-2025 Class II Pinnacle 3 with TumorLOC, (870258) Radiation Th... Jul 17, 2025
Z-1744-2022 Class II Pinnacle3 Radiation Therapy Planning System, Mo... Aug 30, 2022
Z-0213-2020 Class I Forte Gamma Camera System is intended to produc... Sep 19, 2019
Z-0217-2020 Class I Forte Gamma Camera System is intended to produc... Sep 19, 2019

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.